Introduction Continuous subcutaneous insulin infusion (CSII) treatment is beneficial for obtaining glycaemic control for many persons with type 1 diabetes mellitus (T1DM). Still, some individuals do not obtain improved HbA1C levels despite CSII treatment, and there is a lack of evidence regarding how psychosocial factors may influence glycaemic control. Thus, we aimed to explore the attitudes and experiences of self-management among people with T1DM and suboptimal glycaemic control despite CSII treatment. Research design and methods A qualitative inductive design was applied, and four FGDs were performed with 37 adult men and women of various ages and duration of T1DM. All participants had suboptimal glycaemic control despite CSII treatment...
BACKGROUNDDespite increasing importance of patient self-management, little is known about their own ...
Introduction Achieving glycemic targets and optimizing quality of life (QoL) are important goals of ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...
Introduction Continuous subcutaneous insulin infusion (CSII) treatment is beneficial for obtaining g...
Introduction: Continuous subcutaneous insulin infusion (CSII) treatment is beneficial for obtaining ...
BACKGROUND: Conventional insulin therapy requires patients with Type 1 diabetes to adhere to rigid d...
Continuous subcutaneous insulin infusion (CSII) is a complex, medical device for the management of T...
Utilisation of technology in the management of youth with type 1 diabetes has increased substantiall...
Diabetes is a largely self-managed disease with a major psychosocial impact on the lives of patients...
Background: Structured education programmes for patients with diabetes and other chronic conditions ...
Background: Impaired psychological health in type 1 diabetes is prevalent and associated with elevat...
Objectives: To determine whether the impact of guided self-determination (GSD) applied in group trai...
© 2017 John Wiley & Sons Ltd Aim: To use systematic methods to explore the psychosocial facilitators...
Abstract Background Structured education programmes for patients with diabetes and other chronic con...
Aim: To further our understanding of individual use and experience of continuous glucose monitoring ...
BACKGROUNDDespite increasing importance of patient self-management, little is known about their own ...
Introduction Achieving glycemic targets and optimizing quality of life (QoL) are important goals of ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...
Introduction Continuous subcutaneous insulin infusion (CSII) treatment is beneficial for obtaining g...
Introduction: Continuous subcutaneous insulin infusion (CSII) treatment is beneficial for obtaining ...
BACKGROUND: Conventional insulin therapy requires patients with Type 1 diabetes to adhere to rigid d...
Continuous subcutaneous insulin infusion (CSII) is a complex, medical device for the management of T...
Utilisation of technology in the management of youth with type 1 diabetes has increased substantiall...
Diabetes is a largely self-managed disease with a major psychosocial impact on the lives of patients...
Background: Structured education programmes for patients with diabetes and other chronic conditions ...
Background: Impaired psychological health in type 1 diabetes is prevalent and associated with elevat...
Objectives: To determine whether the impact of guided self-determination (GSD) applied in group trai...
© 2017 John Wiley & Sons Ltd Aim: To use systematic methods to explore the psychosocial facilitators...
Abstract Background Structured education programmes for patients with diabetes and other chronic con...
Aim: To further our understanding of individual use and experience of continuous glucose monitoring ...
BACKGROUNDDespite increasing importance of patient self-management, little is known about their own ...
Introduction Achieving glycemic targets and optimizing quality of life (QoL) are important goals of ...
AIMS: Use of blood glucose targets is considered essential to help patients with Type 1 diabetes ach...